Année 2009

Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor downregulation.
Hindlet P, Bado A, Kamenicky P, Deloménie C, Bourasset F, Nazaret C, Farinotti R, Buyse M.
J Biol Chem. 2009;284(11):6801-8.

The Antidepressant Phenelzine Alters Differentiation of Cultured Human and Mouse Preadipocytes.
Chiche F, Le Guillou M, Chetrite G, Lasnier F, Dugail I, Carpene C, Moldes M, Feve B.
Mol Pharmacol. 2009 May;75(5):1052-61.

Effects of stomatostatin analogs on glucose homeostasis: a meta-analysis of acromegaly studies.
Mazziotti G, Floriani I, Bonadonna S, Torri V, Chanson P, Giustina A.
J Clin Endocrinol Metab. 2009 May;94(5):1500-8. 

Lack of Androgen Receptor Expression in Sertoli Cells accounts for the Absence of Anti-Mullerian Hormone Repression during Early Human Testis Development.
Boukari K, Meduri G, Brailly-Tabard S, Guibourdenche J, Ciampi ML, Massin N, Martinerie L, Picard JY, Rey R, Lombès M, Young J.
J Clin Endocrinol Metab. 2009 May;94(5):1818-25.

Merits and pitfalls of mifepristone in Cushing’s syndrome.
Castinetti F, Fassnacht M, Johanssen S, Terzolo M, Bouchard P, Chanson P, Docao C, Morange I, Pico A, Ouzounian S, Young J, Hahner S, Brue T, Allolio B, Conte-Devolx B.
Eur J Endocrinol. 2009 Jun;160(6):1003-10.

VKORC1 genetic polymorphism and risk of venous thromboembolism in postmenopausal women: new findings and metaanalysis.
Verstuyft C, Canonico M, Bouaziz E, Guiochon-Mantel A, Scarabin PY; for the EStrogen and THromboEmbolism Risk (ESTHER) Study Group.
J Thromb Haemost. 2009 Jun;7(6):1034-6.

Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C.
Gelu-Simeon M, Burlaud A, Young J, Pelletier G, Buffet C.
World J Gastroenterol. 2009 Jan 21;15(3):328-33.

Effects of testosterone on ventricular repolarization in hypogonadic men.
Charbit B, Christin-Maître S, Démolis JL, Soustre E, Young J, Funck-Brentano C.
Am J Cardiol. 2009 Mar 15;103(6):887-90. 

Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database.
Webb SM, Strasburger CJ, Mo D, Hartman ML, Melmed S, Jung H, Blum WF, Attanasio AF; HypoCCS International Advisory Board.
J Clin Endocrinol Metab. 2009 Feb;94(2):392-9.

Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults.
Giustina A, Barkan A, Chanson P, Grossman A, Hoffman A, Ghigo E, Casanueva F, Colao A, Lamberts S, Sheppard M, Melmed S; Pituitary Society; European Neuroendocrine Association.
J Endocrinol Invest. 2008 Sep;31(9):820-38.

Does attainment of target levels of growth hormone and insulin-like growth factor I improve acromegaly prognosis?
Chanson P, Maison P.
Nat Clin Pract Endocrinol Metab. 2009 Feb;5(2):70-1.

Mutational status of EGFR, BRAF, PI3KCA and JAK2 genes in endocrine tumors.
Ameur N, Lacroix L, Motte N, Baudin E, Caillou B, Ducreux M, Elias D, Chanson P, Schlumberger M, Bidart JM.
Int J Cancer. 2009 Feb 1;124(3):751-3. 

Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1{alpha} and UCP-1 gene expression in brown adipocytes.
Muraoka M, Fukushima A, Viengchareun S, Lombès M, Kishi F, Miyauchi A, Kanematsu M, Doi J, Kajimura J, Nakai R, Uebi T, Okamoto M, Takemori H.
Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1430-9.

Treatment for 24 months with recombinant human growth hormone has a beneficial effect on bone mineral density in young adults with childhood-onset growth hormone deficiency.
Conway G, Szarras-Czapnik M, Racz K, Keller A, Chanson P, Tauber M, Zacharin M.
Eur J Endocrinol. 2009 Jun;160(6):899-907.

French consensus on the management of acromegaly.
Chanson P, Bertherat J, Beckers A, Bihan H, Brue T, Caron P, Chabre O, Cogne M, Cortet-Rudelli C, Delemer B, Dufour H, Gaillard R, Gueydan M, Morange I, Souberbielle JC, Tabarin A; on behalf of the Club français de l’hypophyse (French Pituitary Club) and of the Société française d’endocrinologie (French Endocrinology Society).
Ann Endocrinol (Paris). 2009 Apr;70(2):92-106.

Benefits of Ophdiat((R)), a telemedical network to screen for diabetic retinopathy: A retrospective study in five reference hospital centres.
Chabouis A, Berdugo M, Meas T, Erginay A, Laloi-Michelin M, Jouis V, Guillausseau PJ, M’bemba J, Chaine G, Slama G, Cohen R, Reach G, Marre M, Chanson P, Vicaut E, Massin P.
Diabetes Metab. 2009 Jun;35(3):228-32.

Growth hormone excess and sternohyoid muscle mechanics in rats.
Attal P, Claes V, Bobin S, Chanson P, Kamenicky P, Zizzari P, Lecarpentier Y.
Eur Respir J. 2009 Oct;34(4):967-74. 

Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.
Tordjman S, Anderson GM, Botbol M, Brailly-Tabard S, Perez-Diaz F, Graignic R, Carlier M, Schmit G, Rolland AC, Bonnot O, Trabado S, Roubertoux P, Bronsard G.
PLoS One. 2009 Aug 26;4(8):e5289.

The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.
Louiset E, Stratakis CA, Perraudin V, Griffin KJ, Libé R, Cabrol S, Fève B, Young J, Groussin L, Bertherat J, Lefebvre H.
J Clin Endocrinol Metab. 2009 Jul;94(7):2406-13.

Low Renal Mineralocorticoid Receptor Expression at Birth Contributes to Partial Aldosterone Resistance in Neonates.
Martinerie L, Viengchareun S, Delezoïde AL, Jaubert F, Sinico M, Prevot S, Boileau P, Meduri G, Lombès M.
Endocrinology. 2009 Sep;150(9):4414-24.

Ce travail a été sélectionné et évalué par un membre du « Faculty of 1000″, qui a classé cet article dans le Top 2% des articles publiés en biologie et en médecine.

D3 growth hormone receptor polymorphism is not associated with IGF-1 levels in untreated acromegaly.
Kamenicky P, Dos Santos C, Espinosa C, Salenave S, Galland F, Le Bouc Y, Maison P, Bougneres P, Chanson P.
Eur J Endocrinol. 2009 Aug;161(2):231-5.

Isolated Familial Hypogonadotropic Hypogonadism and a GNRH1 Mutation.
Bouligand J, Ghervan C, Tello JA, Brailly-Tabard S, Salenave S, Chanson P, Lombès M, Millar RP, Guiochon-Mantel A, Young J.
N Engl J Med. 2009 Jun 25;360(26):2742-8. 

Physiological Partial Aldosterone Resistance in Human Newborns.
Martinerie L, Pussard E, Foix-L hélias L, Petit F, Cosson C, Boileau P, Lombès M.
Pediatr Res. 2009 Sep;66(3):323-8.

[Menometrorrhagia: to whom, why, on which criteria to propose a hormonal exploration?]
Brailly-Tabard S, Trabado S, Khallouf O.
J Gynecol Obstet Biol Reprod (Paris). 2008 Dec;37 Suppl 8:S329-33.

Osmotic Stress Regulates Mineralocorticoid Receptor Expression in a Novel Aldosterone-Sensitive Cortical Collecting Duct Cell Line.
Viengchareun S, Kamenicky P, Teixeira M, Butlen D, Meduri G, Blanchard-Gutton N, Kurschat C, Lanel A, Martinerie L, Sztal-Mazer S, Blot-Chabaud M, Ferrary E, Cherradi N, Lombès M.
Mol Endocrinol. 2009 Dec;23(12):1948-62.

Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
Bouaziz E, Canonico M, Verstuyft C, Carcaillon L, Martin F, Scarabin PY, Guiochon-Mantel A; EStrogen, THromboEmbolism Risk (ESTHER) Study Group.
Maturitas. 2009 Oct 20;64(2):136-8.

[GNRH1 mutation in familial hypogonadotropic hypogonadism.]
Bouligand J, Guiochon-Mantel A, Young J.
Med Sci (Paris). 2009 Oct;25(10):791-793.

The role of interleukins in insulin resistance and type 2 diabetes mellitus.
Fève B, Bastard JP.
Nat Rev Endocrinol. 2009 Jun;5(6):305-11. 

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness]
Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.
Encephale. 2009 Sep;35(4):330-9.

Mineralocorticoid receptors in the metabolic syndrome.
Zennaro MC, Caprio M, Fève B.
Trends Endocrinol Metab. 2009 Nov;20(9):444-51.

[SF-1, a key player in adrenal and gonadal differentiation: implications in gonadal dysgenesis and primary ovarian insufficiency.]
Martinerie L, Bouvattier C, Lombes M.
Ann Endocrinol (Paris). 2009 Sep;70S1:S26-S32.

Long-term results of stereotactic radiosurgery in secretory pituitary adenomas.
Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, Cortet-Rudelli C, Kuhn JM, Conte-Devolx B, Regis J, Brue T.
J Clin Endocrinol Metab. 2009 Sep;94(9):3400-7.

Pituitary tumours: acromegaly.
Chanson P, Salenave S, Kamenicky P, Cazabat L, Young J.
Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):555-74.

A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
Sarfati J, Guiochon-Mantel A, Rondard P, Arnulf I, Garcia-Piñero A, Wolczynski S, Brailly-Tabard S, Bidet M, Ramos-Arroyo M, Mathieu M, Lienhardt-Roussie A, Morgan G, Turki Z, Bremont C, Lespinasse J, Du Boullay H, Chabbert-Buffet N, Jacquemont S, Reach G, De Talence N, Tonella P, Conrad B, Despert F, Delobel B, Brue T, Bouvattier C, Cabrol S, Pugeat M, Murat A, Bouchard P, Hardelin JP, Dodé C, Young J.
J Clin Endocrinol Metab. 2010 Feb;95(2):659-69.

Physiologie et exploration des sécrétions de cortisol et d’androgènes par la surrénale
Oudet B, Rigabert J, Young J, Raffin-Sanson M.-L
EMC, 2009, sous presse

Reference intervals for urinary catecholamines and metabolites from birth to adulthood.
Pussard E, Neveux M, Guigueno N.
Clin Biochem. 2009 Apr;42(6):536-9.

Various actions of aldosterone: The kidney and beyond…
Lombès M.
Ann Endocrinol (Paris). 2009 Jun;70(3):173-5.